Index of medicine substances

Famciclovir  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB09)

Famotidine  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | H2-receptor antagonists (A02BA03)

Fampridine  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX07)

Faricimab  •  Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents (S01LA09)

Favipiravir  •  Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX27)

Febuxostat  •  Musculo-skeletal system | Antigout preparations | Antigout preparations | Preparations inhibiting uric acid production (M04AA03)

Fedratinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors (L01EJ02)

Felodipine  •  Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives (C08CA02)

Fenfluramine  •  Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX26)

Fenofibrate  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Fibrates (C10AB05)

Fenofibrate + simvastatin  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Combinations of various lipid modifying agents (C10BA04)

Fenspiride  •  Respiratory system | Other systemic drugs for obstructive airway diseases (R03DX03)

Fentanyl  •  Nervous system | Opioids | Phenylpiperidine derivatives (N02AB03)

Fenticonazole  •  Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Imidazole derivatives (G01AF12)

Ferocolinate  •  Blood and blood forming organs | Iron preparations | Iron trivalent, oral preparations (B03ABN1)

Ferrous fumarate + folic acid  •  Blood and blood forming organs | Iron preparations | Iron in combination with folic acid (B03AD02)

Ferrous gluconate + folic acid  •  Blood and blood forming organs | Iron preparations | Iron in combination with folic acid (B03AD05)

Ferrous gluconate + manganese gluconate + copper gluconate  •  Blood and blood forming organs | Iron preparations | Iron in other combinations (B03AE10)

Ferrous glycine sulfate + folic acid + cyanocobalamin  •  Blood and blood forming organs | Iron preparations | Iron in combination with folic acid (B03AD03)

Ferucarbotran  •  Various | Magnetic resonance imaging contrast media | Superparamagnetic contrast media (V08CB03)

Fesoterodine  •  Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs for urinary frequency and incontinence (G04BD11)

Fexofenadine  •  Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Other antihistamines for systemic use (R06AX26)

Fezolinetant  •  Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals (G02CX06)

Fibrinogen + thrombin  •  Blood and blood forming organs | Vitamin k and other hemostatics | Local hemostatics (B02BC30)

Fidaxomycin  •  Alimentary tract and metabolism | Intestinal antiinfectives | Antibiotics (A07AA12)

Filgotinib  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Janus-associated kinase (JAK) inhibitors (L04AF04)

Filgrastim (G-CSF)  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Colony stimulating factors (L03AA02)

Finasteride  •  Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Testosterone-5-alpha reductase inhibitors (G04CB01)

Finerenone  •  Cardiovascular system | Potassium-sparing agents | Aldosterone antagonists (C03DA05)

Fingolimoda  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Sphingosine-1-phosphate (S1P) receptor modulators (L04AE01)